Fiona M. Gribble
Affiliations: | Clinical Biochemistry | University of Cambridge, Cambridge, England, United Kingdom |
Google:
"Fiona Gribble"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lewis JE, Nuzzaci D, James-Okoro PP, et al. (2024) Stimulating intestinal GIP release reduces food intake and body weight in mice. Molecular Metabolism. 101945 |
| Foreman RE, Bannon CA, Kay RG, et al. (2024) Motilin fluctuations in healthy volunteers determined by liquid chromatography mass spectrometry. Frontiers in Endocrinology. 15: 1348146 |
| Bannon CA, Meek CL, Reimann F, et al. (2024) Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants. Peptides. 176: 171186 |
| Santos Hernandez M, Reimann F, Gribble FM. (2024) Cellular mechanisms of incretin hormone secretion. Journal of Molecular Endocrinology |
| Bany Bakar R, Reimann F, Gribble FM. (2023) The intestine as an endocrine organ and the role of gut hormones in metabolic regulation. Nature Reviews. Gastroenterology & Hepatology |
| Foreman RE, Miedzybrodzka EL, Eiríksson FF, et al. (2023) Optimized LC-MS/MS Method for the Detection of ppCCK(21-44): A Surrogate to Monitor Human Cholecystokinin Secretion. Journal of Proteome Research. 22: 2950-2958 |
| Adriaenssens A, Broichhagen J, de Bray A, et al. (2023) Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding. Jci Insight. 8 |
| Hayashi M, Kaye JA, Douglas ER, et al. (2023) Enteroendocrine cell lineages that differentially control feeding and gut motility. Elife. 12 |
| George AL, Foreman RE, Sayda MH, et al. (2023) Rapid and Quantitative Enrichment of Peptides from Plasma for Mass Spectrometric Analysis. Methods in Molecular Biology (Clifton, N.J.). 2628: 477-488 |
| Wagner S, Brierley DI, Leeson-Payne A, et al. (2022) Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression. Molecular Metabolism. 68: 101665 |